PROEHL GERALD T
- SEC CIK
- 0001279191
Latest role at each company
- DRMA Dermata Therapeutics, Inc.PRESIDENT, CHAIRMAN, CEOas of Aug 18, 2026
- TENX TENAX THERAPEUTICS, INC.Directoras of Jan 13, 2026
Trades
Every Form 4 that lists PROEHL GERALD T as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| TENXTENAX THERAPEUTICS, INC. | Aug 8, 2024 | Aug 8, 2024 | PROEHL GERALD TDirector | PPurchaseCommon Stock | +1.67K | – | – | 1.67K | +166,600.0% | SEC |
| TENXTENAX THERAPEUTICS, INC. | Aug 8, 2024 | Aug 8, 2024 | PROEHL GERALD TDirector | PPurchaseCommon Stock · Derivative | +48.31K | – | – | 16.66K | – | SEC |
| DRMADermata Therapeutics, Inc. | Nov 26, 2021 | Nov 23, 2021 | PROEHL GERALD TPresident, CEO and Chairman | PPurchaseCommon Stock | +20K | $2.40 | +$48K | 59.51K | +50.6% | SEC |
| DRMADermata Therapeutics, Inc. | Aug 17, 2021 | Aug 16 – Aug 17, 2021 | PROEHL GERALD TPresident, CEO and Chairman | PPurchaseCommon Stock | +152.86K | $4.96 | +$49.6K | 152.86K | New position | SEC |
| DRMADermata Therapeutics, Inc. | Aug 17, 2021 | Aug 17, 2021 | PROEHL GERALD TPresident, CEO and Chairman | PPurchaseCommon Stock · Derivative | +142.86K | – | – | 142.86K | – | SEC |